Stayble Therapeutics AB (publ) (FRA:4K4)
Germany flag Germany · Delayed Price · Currency is EUR
0.0162
-0.0010 (-5.81%)
Last updated: Jan 27, 2026, 3:25 PM CET

Stayble Therapeutics AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3.82.214.0812.8537.4710.87
Cash & Short-Term Investments
3.82.214.0812.8537.4710.87
Cash Growth
--84.41%9.60%-65.71%244.77%184.28%
Other Receivables
0.180.130.250.610.450.35
Receivables
0.180.130.250.610.450.35
Prepaid Expenses
0.271.281.720.040.080.03
Other Current Assets
-0----1.1
Total Current Assets
4.253.6116.0513.537.9912.35
Long-Term Investments
----0-
Long-Term Deferred Charges
5.655.655.655.655.655.65
Other Long-Term Assets
0-----
Total Assets
9.99.2621.719.1543.6418
Accounts Payable
0.190.272.551.040.430.72
Accrued Expenses
0.171.071.561.822.20.39
Other Current Liabilities
0.230.20.230.150.350.29
Total Current Liabilities
0.591.534.343.022.981.4
Long-Term Debt
0.850.850.850.850.851.04
Other Long-Term Liabilities
0-----
Total Liabilities
1.442.385.193.873.832.45
Common Stock
8.375.684.121.81.80.9
Additional Paid-In Capital
---36.0848.1830.96
Retained Earnings
-1.83-0.7310.46-24.53-12.09-18.23
Comprehensive Income & Other
1.921.921.921.921.921.92
Shareholders' Equity
8.466.8716.5115.2839.8115.55
Total Liabilities & Equity
9.99.2621.719.1543.6418
Total Debt
0.850.850.850.850.851.04
Net Cash (Debt)
2.951.3513.231236.629.82
Net Cash Growth
--89.83%10.28%-67.24%272.78%297.24%
Net Cash Per Share
0.050.040.510.872.641.42
Filing Date Shares Outstanding
64.3651.7231.7213.8513.856.92
Total Common Shares Outstanding
64.3643.7231.7213.8513.856.92
Working Capital
3.662.0711.7110.4835.0110.94
Book Value Per Share
0.130.160.521.102.872.25
Tangible Book Value
8.466.8716.5115.2839.8115.55
Tangible Book Value Per Share
0.130.160.521.102.872.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.